Cndp2-KO Mouse
Common Name
Cndp2-KO
제품 ID
S-KO-11504
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-66054-Cndp2-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Cndp2-KO Mouse (카탈로그 번호 S-KO-11504)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Cndp2-KO
품종 계통계통 ID
KOCMP-66054-Cndp2-B6J-VA
유전자명
제품 ID
S-KO-11504
유전자 별칭
Cn2, Pep1, Dip-2, Pep-1, 0610010E05Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 18
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000168419
NCBI 전사체 ID
NM_001289531.1
타겟 영역
Exon 2~3
유효 영역 크기
~3.1 kb
유전자 연구 개요
CNDP2, also known as carnosine dipeptidase II, is an enzyme with multiple essential functions. It catalyzes the formation of Lac-Phe, an exercise-induced metabolite from lactate, and is involved in lactate clearance, carnosine hydrolysis, oxidative stress regulation, and metabolite regulation. It is also associated with cardiometabolic, renal diseases, and has implications in cancer-related pathways such as PI3K/AKT, MAPK, and cooperative nutrient scavenging in the tumor microenvironment [1,4,6,9]. Genetic models, like KO mouse models, are valuable for studying its functions.
In KO mouse models, genetic ablation of CNDP2 eliminates tissue amino acid BHB-ylation activity and reduces BHB-amino acid levels, leading to increased food intake and body weight upon ketosis stimuli or exogenous ketone ester supplementation [2,8]. In the context of metformin's action, genetic ablation of CNDP2 in mice renders them resistant to metformin's anorexigenic and anti-obesity effects, establishing the CNDP2/Lac-Phe pathway as a critical mediator of metformin's effects on energy balance [3,7]. Also, CNDP2 KO mice show aggravated hepatic and renal damage upon an acetaminophen overdose, indicating its role in protecting cells under cysteine insufficiency [5].
In conclusion, CNDP2 is a key enzyme in multiple biological processes. Model-based research, especially through KO mouse models, has revealed its role in energy balance, metabolite regulation, and cell protection under stress. In diseases, it is implicated in cardiometabolic, renal conditions, and cancer, highlighting its potential as a therapeutic target.
References:
1. Ocariza, Moizle Grace Castro, Paton, Louise Nancy, Templeton, Evelyn Mary, Pilbrow, Anna Pauline, Appleby, Sarah. 2024. CNDP2: An Enzyme Linking Metabolism and Cardiovascular Diseases? In Journal of cardiovascular translational research, 18, 48-57. doi:10.1007/s12265-024-10560-4. https://pubmed.ncbi.nlm.nih.gov/39349903/
2. Moya-Garzon, Maria Dolores, Wang, Mengjie, Li, Veronica L, Xu, Yong, Long, Jonathan Z. 2024. A β-hydroxybutyrate shunt pathway generates anti-obesity ketone metabolites. In Cell, 188, 175-186.e20. doi:10.1016/j.cell.2024.10.032. https://pubmed.ncbi.nlm.nih.gov/39536746/
3. Xiao, Shuke, Li, Veronica L, Lyu, Xuchao, Benson, Mark D, Long, Jonathan Z. 2024. Lac-Phe mediates the effects of metformin on food intake and body weight. In Nature metabolism, 6, 659-669. doi:10.1038/s42255-024-00999-9. https://pubmed.ncbi.nlm.nih.gov/38499766/
4. Zhang, Li Q, Yang, Hua Q, Yang, Su Q, Lu, Hong S, Zhao, Ling P. . CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway. In Technology in cancer research & treatment, 18, 1533033819874773. doi:10.1177/1533033819874773. https://pubmed.ncbi.nlm.nih.gov/31537175/
5. Kobayashi, Sho, Homma, Takujiro, Okumura, Nobuaki, Takao, Toshifumi, Fujii, Junichi. 2021. Carnosine dipeptidase II (CNDP2) protects cells under cysteine insufficiency by hydrolyzing glutathione-related peptides. In Free radical biology & medicine, 174, 12-27. doi:10.1016/j.freeradbiomed.2021.07.036. https://pubmed.ncbi.nlm.nih.gov/34324979/
6. Zhang, Zhenwei, Miao, Lei, Xin, Xiaoming, Kong, Xiangping, Jiao, Binghua. 2014. Underexpressed CNDP2 participates in gastric cancer growth inhibition through activating the MAPK signaling pathway. In Molecular medicine (Cambridge, Mass.), 20, 17-28. doi:10.2119/molmed.2013.00102. https://pubmed.ncbi.nlm.nih.gov/24395568/
7. Xiao, Shuke, Li, Veronica L, Lyu, Xuchao, Benson, Mark D, Long, Jonathan Z. 2023. Lac-Phe mediates the anti-obesity effect of metformin. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.11.02.565321. https://pubmed.ncbi.nlm.nih.gov/37961394/
8. Moya-Garzon, Maria Dolores, Wang, Mengjie, Li, Veronica L, Xu, Yong, Long, Jonathan Z. 2024. A secondary β-hydroxybutyrate metabolic pathway linked to energy balance. In bioRxiv : the preprint server for biology, , . doi:10.1101/2024.09.09.612087. https://pubmed.ncbi.nlm.nih.gov/39314488/
9. Guzelsoy, Gizem, Elorza, Setiembre D, Ros, Manon, Papagiannakopoulos, Thales, Carmona-Fontaine, Carlos. 2025. Cooperative nutrient scavenging is an evolutionary advantage in cancer. In Nature, 640, 534-542. doi:10.1038/s41586-025-08588-w. https://pubmed.ncbi.nlm.nih.gov/39972131/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.